Gram-positive bacterial infections
MONDO:0021679Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method.
Also known as: Gram Positive bacterial infections, Gram-positive bacterial infection, Gramme Positive bacterial infections, bacterial infection, Gram-positive, bacterial infections, Gram Positive, bacterial infections, Gram-positive, bacterial infections, Gramme Positive, infection, Gram-positive bacterial
253 clinical trials for this condition and its sub-types, 7 tagged with Gram-positive bacterial infections itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Gram-positive bacterial infections
-
Streptococcal infection 19 trials · 132 incl. sub-types
8 sub-types
- Pneumococcal infection 90 trials · 100 incl. sub-types Sub-types →
- Group B streptococcal infection 9 trials
- Streptococcal sore throat 8 trials
- Impetigo 5 trials Sub-types →
- Erysipelas 1 trial
- Streptococcal toxic-shock syndrome 1 trial
- Scarlet fever 0 trials
- Streptococcal meningitis 0 trials Sub-types →
-
Clostridium infectious disease 48 trials · 97 incl. sub-types
3 sub-types
- Tetanus 44 trials Sub-types →
- Botulism 5 trials Sub-types →
- Infection due to clostridium perfringens 0 trials Sub-types →
-
Bacillaceae infectious disease 1 trial · 20 incl. sub-types
1 sub-type
- Anthrax infection 17 trials · 20 incl. sub-types Sub-types →
-
1 sub-type
- Actinomycosis 0 trials Sub-types →
-
Erysipelothrix infectious disease 0 trials
1 sub-type
-
Infection caused by Bifidobacterium 0 trials
Most studied deeper sub-types
-
Can a new pill shorten tuberculosis treatment?
Disease control CompletedThis trial tests an experimental antibiotic called BTZ-043 in adults with newly diagnosed, drug-sensitive pulmonary tuberculosis. Participants take the drug by mouth once daily for 14 days, and researchers compare it to a standard combination treatment. The main goal is to check …
Phase 1/2 • Sponsor: Michael Hoelscher • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New antibiotic oritavancin tested in kids for safety and dosing
Disease control CompletedThis study tested a single dose of the antibiotic oritavancin in 41 children under 18 with suspected or confirmed bacterial infections. The goal was to find the right dose and check for safety and side effects. It was an early-stage trial, so it focused on how the drug moves thro…
Phase 1 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a tailored antibiotic dose save more kids in the ICU?
Knowledge-focused CompletedThis study tested whether giving a personalized dose of the antibiotic vancomycin to critically ill children in the ICU leads to better results than the standard approach. Researchers enrolled 314 children and compared how many reached the target drug level in their blood. The go…
Phase 4 • Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC